# Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome

> **NCT03487783** · PHASE3 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 121 (actual)

## Conditions studied

- Tourette Syndrome

## Interventions

- **DRUG:** Aripiprazole Oral Solution
- **DRUG:** Placebo Oral Solution

## Key facts

- **NCT ID:** NCT03487783
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-02
- **Primary completion:** 2020-02-14
- **Final completion:** 2020-02-14
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2020-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03487783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03487783, "Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03487783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*